Collecting Pharma’s Scraps Can Pay Off for This Biotech
Read Time:6 Second
Roivant has built a unique model that allows it to benefit from big pharma’s need to reduce R&D spending.
Norway's gigantic sovereign wealth fund on Tuesday reported third-quarter profit of 835 billion Norwegian kroner ($76.3 billion).
European natural-gas prices edged higher in late morning trade, boosted by heightened geopolitical tensions and a colder weather forecast for...